ASHLEY WISE: Open Payments
NPI 1912668799 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,731 in 153 payments from 18 companies in 2025. Trend: 2023 $2,123 · 2024 $1,425 · 2025 $3,731
Food & beverage: $3,281Consulting: $450
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $1,134 |
| Janssen Biotech, Inc. | 21 | $644 |
| ABBVIE INC. | 30 | $476 |
| Ardelyx, Inc. | 14 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $211 |
| Madrigal Pharmaceuticals | 8 | $183 |
| Ipsen Biopharmaceuticals, Inc | 13 | $155 |
| GENZYME CORPORATION | 4 | $110 |
| PFIZER INC. | 4 | $79 |
| Daiichi Sankyo Inc. | 4 | $71 |
Products named: XIFAXAN, TREMFYA, IBSRELA, ENTYVIO, REZDIFFRA, RINVOQ, IQIRVO, DUPIXENT.
Industry payments across GA — which companies pay providers there.
